吉非替尼与标准化疗对EGFR突变的晚期非小细胞肺癌患者疗效和安全性的比较
评价者:王洁
1
, 文献合成者:黄玲
2
The Efficacy and Safety Profile of Gefitinib versus Standard Chemotherapy for Non-Small Cell Lung Cancer with Mutated EGFR
Reviewer:WANG Jie
1
, Literature Co-worker: HUANG Ling
2
图1 研究的随机分层方案与治疗方法